Anna Ostergaard

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Journal: Blood

Published: August 29, 2025

Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Journal: Blood

Published: August 29, 2025

Genomic Subclassification and Risk Stratification of ALL.

Genomic Subclassification and Risk Stratification of ALL.

Journal: Acta haematologica

Published: April 14, 2025

IKZF1 in acute lymphoblastic leukemia: the rise before the fall?

IKZF1 in acute lymphoblastic leukemia: the rise before the fall?

Journal: Leukemia & lymphoma

Published: August 30, 2024

Secondary lesions and sensitivity to signaling inhibitors in iAMP21 acute lymphoblastic leukemia.

Secondary lesions and sensitivity to signaling inhibitors in iAMP21 acute lymphoblastic leukemia.

Journal: HemaSphere

Published: August 20, 2024

ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?

ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?

Journal: Leukemia

Published: January 23, 2023

The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia.

The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia.

Journal: HemaSphere

Published: August 31, 2022

Socioeconomic position and maintenance therapy in children with acute lymphoblastic leukemia: A national cohort study.

Socioeconomic position and maintenance therapy in children with acute lymphoblastic leukemia: A national cohort study.

Journal: Pediatric blood & cancer

Published: July 05, 2021

Acute lymphoblastic leukemia and down syndrome: 6-mercaptopurine and methotrexate metabolites during maintenance therapy.

Acute lymphoblastic leukemia and down syndrome: 6-mercaptopurine and methotrexate metabolites during maintenance therapy.

Journal: Leukemia

Published: February 10, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026